Pharmacophore-based discovery of a novel cytosolic phospholipase A2α inhibitor

Graphical abstract

[1]  C. Leslie,et al.  The 85-kDa, arachidonic acid-specific phospholipase A2 is expressed as an activated phosphoprotein in Sf9 cells. , 1993, Archives of biochemistry and biophysics.

[2]  Y. Ouchi,et al.  A potent inhibitor of cytosolic phospholipase A2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[3]  Y. Kurogi,et al.  Pharmacophore modeling and three-dimensional database searching for drug design using catalyst. , 2001, Current medicinal chemistry.

[4]  D. Steinhilber,et al.  Picomole determination of 2,4-dimethoxyanilides of prostaglandins by high-performance liquid chromatography with electrochemical detection. , 1988, Journal of chromatography.

[5]  Marzieh Niknami,et al.  Molecules in focus: cytosolic phospholipase A2-alpha. , 2009, The international journal of biochemistry & cell biology.

[6]  V. Magrioti,et al.  Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases , 2010, Expert opinion on therapeutic patents.

[7]  T. Langer,et al.  Morphinans and isoquinolines: acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors. , 2010, Bioorganic & medicinal chemistry.

[8]  J. D. Clark,et al.  Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib. , 2008, Journal of medicinal chemistry.

[9]  J. Haeggström,et al.  Advances in eicosanoid research, novel therapeutic implications. , 2010, Biochemical and biophysical research communications.

[10]  Sheng-Yong Yang,et al.  Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.

[11]  J. Miyazaki,et al.  Role of cytosolic phospholipase A2 in allergic response and parturition , 1997, Nature.

[12]  J. D. Clark,et al.  Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2alpha: optimization of in vitro potency and rat pharmacokinetics for oral efficacy. , 2008, Bioorganic & medicinal chemistry.

[13]  T. Langer.  Pharmacophores in Drug Research , 2010, Molecular informatics.

[14]  M. Gelb,et al.  Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer , 2008, Clinical Cancer Research.

[15]  D. Reinhardt,et al.  1-(5-carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A(2)alpha with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity. , 2010, Journal of medicinal chemistry.

[16]  M. Lehr,et al.  Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha. , 2006, Journal of medicinal chemistry.

[17]  E. Dennis,et al.  Inhibition of group IVA cytosolic phospholipase A2 by novel 2-oxoamides in vitro, in cells, and in vivo. , 2004, Journal of medicinal chemistry.

[18]  Y. Gahara,et al.  Cytosolic phospholipase A2 alpha inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destructive action in a murine arthritis model , 2009, Inflammation Research.

[19]  Robert D. Clark,et al.  Managing bias in ROC curves , 2008, J. Comput. Aided Mol. Des..

[20]  S. Noha,et al.  Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques , 2011, Bioorganic & medicinal chemistry letters.

[21]  M. Lehr,et al.  1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis, biological activity, metabolic stability, and solubility. , 2008, Bioorganic & medicinal chemistry.

[22]  Richard A. Lewis,et al.  Three-dimensional pharmacophore methods in drug discovery. , 2010, Journal of medicinal chemistry.

[23]  S. Khor,et al.  Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α2α , 2007 .

[24]  D. Murray,et al.  Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A(2) based on a 1,3-disubstituted propan-2-one skeleton. , 2002, Journal of medicinal chemistry.

[25]  D. Murray,et al.  Synthesis and evaluation of substrate-mimicking cytosolic phospholipase A2 inhibitors--reducing the lipophilicity of the arachidonyl chain isostere. , 2004, Bioorganic & medicinal chemistry letters.

[26]  J. D. Clark,et al.  In vitro allergen challenge of peripheral blood induces differential gene expression in mononuclear cells of asthmatic patients: inhibition of cytosolic phospholipase A2α overcomes the asthma-associated response , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  Takao Shimizu,et al.  Cytosolic phospholipase A2: Biochemical properties and physiological roles , 2006, IUBMB life.

[28]  J. Pin,et al.  Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. , 2005, Journal of medicinal chemistry.